Marcus CV - Search Results

1

Differences in Failure-Free Survival After Salvage Radiotherapy Guided by Conventional Imaging Versus ¹⁸F-Fluciclovine PET/CT in Postprostatectomy Patients: A Post Hoc Substratification Analysis of the EMPIRE-1 Trial.

Lawal IO, Jani AB, Adediran OA, Goyal S, Abiodun-Ojo OA, Dhere VR, Marcus CV, Joshi SS, Master VA, Patel PR, Goodman M, Shelton JW, Kucuk O, Hershatter B, Fielder B, Halkar RK, Schuster DM. Lawal IO, et al. Among authors: marcus cv. J Nucl Med. 2023 Apr;64(4):586-591. doi: 10.2967/jnumed.122.264832. Epub 2022 Nov 3. J Nucl Med. 2023. PMID: 36328489 Free PMC article.

2

Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.

Antoniou AJ, Marcus C, Tahari AK, Wahl RL, Subramaniam RM. Antoniou AJ, et al. J Nucl Med. 2014 Jul;55(7):1062-8. doi: 10.2967/jnumed.113.136770. Epub 2014 Apr 28. J Nucl Med. 2014. PMID: 24777290 Free PMC article.

3

Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.

Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL, Kiess AP, Kang H, Subramaniam RM. Marcus C, et al. J Nucl Med. 2014 Sep;55(9):1411-6. doi: 10.2967/jnumed.113.136796. Epub 2014 Jun 19. J Nucl Med. 2014. PMID: 24947059 Free PMC article.

4

18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.

Sheikhbahaei S, Mena E, Marcus C, Wray R, Taghipour M, Subramaniam RM. Sheikhbahaei S, et al. J Nucl Med. 2016 Jun;57(6):855-60. doi: 10.2967/jnumed.115.165480. Epub 2016 Feb 2. J Nucl Med. 2016. PMID: 26837337 Free article.

5

Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up ¹⁸F-FDG PET/CT Scans in Oncology Patients.

Taghipour M, Marcus C, Sheikhbahaei S, Mena E, Prasad S, Jha AK, Solnes L, Subramaniam RM. Taghipour M, et al. J Nucl Med. 2017 May;58(5):737-743. doi: 10.2967/jnumed.116.183111. Epub 2016 Nov 3. J Nucl Med. 2017. PMID: 27811123 Free PMC article.

6

Whole-Body ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Sheikhbahaei S, Marcus CV, Fragomeni RS, Rowe SP, Javadi MS, Solnes LB. Sheikhbahaei S, et al. Among authors: marcus cv. J Nucl Med. 2017 Jul;58(7):1031-1036. doi: 10.2967/jnumed.116.183905. Epub 2016 Dec 15. J Nucl Med. 2017. PMID: 27980049 Free article. Review.

7

Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.

Sheikhbahaei S, Ahn SJ, Young B, Taghipour M, Marcus C, Subramaniam RM. Sheikhbahaei S, et al. Nucl Med Commun. 2017 Aug;38(8):720-725. doi: 10.1097/MNM.0000000000000707. Nucl Med Commun. 2017. PMID: 28678114

8

Ring Sclerosis in Prostate Cancer: Circle of Malignancy or Benignity?

Marcus C, Baum Y, Abiodun-Ojo OA, Jani AB, Schuster DM. Marcus C, et al. Clin Nucl Med. 2021 May 1;46(5):e286-e289. doi: 10.1097/RLU.0000000000003434. Clin Nucl Med. 2021. PMID: 33315669 Free PMC article.

9

Clinical utility of ¹⁸F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels.

Marcus C, Abiodun-Ojo OA, Jani AB, Schuster DM. Marcus C, et al. Am J Nucl Med Mol Imaging. 2021 Oct 15;11(5):406-414. eCollection 2021. Am J Nucl Med Mol Imaging. 2021. PMID: 34754611 Free PMC article.

10

Incidental Spinal Meningioma on an 18F-Fluciclovine PET/CT.

Marcus C, Baugnon K, Schuster DM. Marcus C, et al. Clin Nucl Med. 2022 Mar 1;47(3):e313-e314. doi: 10.1097/RLU.0000000000004044. Clin Nucl Med. 2022. PMID: 35025777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters